The fibrinolytic system: from Petri dishes to genetic engineering.
Verstraete
M
M
Center for Molecular and Vascular Biology, University of Leuven, Belgium.
D000595:Amino Acid Sequence; D000818:Animals; D002685:Chiroptera; D004285:Dogs; D005060:Europe; D005342:Fibrinolysis / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D005343:Fibrinolytic Agents / Q000737:chemistry / Q000266:history / Q000627:therapeutic use*; D005818:Genetic Engineering; D006405:Hematology / Q000266:history; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D008545:Melanoma / Q000473:pathology; D008969:Molecular Sequence Data; D015337:Multicenter Studies as Topic; D010960:Plasminogen Activators / Q000737:chemistry / Q000627:therapeutic use; D011487:Protein Conformation; D011817:Rabbits; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D011994:Recombinant Proteins / Q000737:chemistry / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy; D015912:Thrombolytic Therapy / Q000266:history; D014407:Tumor Cells, Cultured; D014481:United States
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010960:Plasminogen Activators